F2RL1 and brain inflammatory disease: In our experimental conditions, using LPS-activated mouse microglia, treatment with 1-PPA induced a significant downregulation of PAR2 which was associated with a significant decrease in inflammatory cytokines synthesis, providing evidence that this small molecule can control brain inflammation.